Status:
COMPLETED
A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy
Eligibility:
All Genders
16+ years
Phase:
PHASE4
Brief Summary
Patients in community-based practices correspond to the 25% of patients who need a first add-on drug when not controlled by their standard monotherapy drug. This was a therapeutic use trial in which t...
Eligibility Criteria
Inclusion
- partial onset seizures with or without secondary generalisation with epilepsy.
Exclusion
- hypersensitivity to levetiracetam or other pyrrolidone derivatives or to any of the excipients.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00631150
Start Date
March 1 2003
End Date
July 1 2004
Last Update
November 15 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.